Anika Therapeutics Inc., of Woburn, Mass., promoted Randall Wilhoite to vice president of operations.

Apogee Technology Inc., of Norwood, Mass., named Hans Wigzell to its scientific advisory board.

Ariad Pharmaceuticals Inc., of Cambridge, Mass., appointed Ross Pettit vice president of clinical operations.

Avicena Group Inc., of Palo Alto, Calif., appointed M. Flint Beal to its board.

Bavarian Nordic, of Kvistgard, Denmark, appointed Nicholai Andersen executive vice president of commercial affairs, effect Nov. 16, 2007.

BioVex Inc., of Woburn, Mass., appointed Leonard Post to its board.

BiPar Sciences Inc., of Brisbane, Calif., named G. Kirk Raab acting CEO and appointed Eric Malek vice president of corporate development and Deborah Thomas vice president for regulatory affairs.

BT Pharma SA, of Toulouse, France, elected Martin Koch as vice president of finance and administration.

Cardio3BioSciences, of Braine L-Alleud, Belgium, appointed Vinciane Gaussin chief scientific officer and Patrick Jeanmart chief financial officer.

Ceapro Inc., of Edmonton, Alberta, named Glenn Rourke to its board.

Cellectar LLC, of Madison, Wis., appointed Ernest Allen director of clinical operations and LisaAnn Trembath manager of medical affairs.

Cell Therapeutics Inc., of Seattle, appointed Richard Love to its board.

Ceregene Inc., of San Diego, appointed Joao Siffert vice president and chief medical officer.

Cougar Biotechnology Inc., of Los Angeles, appointed Samuel Saks to its board.

CuraGen Corp., of Branford, Conn., named Ronit Simantov vice president of medical development.

DBV Technologies, of Paris, named Hing Kin Chan chief business officer, Florian Reinaud chief financial officer and Laurent Martin regulatory affairs director.

Elusys Therapeutics Inc., of Pine Brook, N.J., appointed Robert Love chief financial officer.

EnVivo Pharmaceuticals Inc., of Watertown, Mass., appointed Dana Hilt senior vice president and chief medical officer.

EraGen BioSciences Inc., of Madison, Wis., appointed L. Miguel Blanc vice president of corporate development.

Essex Woodlands Health Ventures, of New York, appointed Karen Katen senior advisor.